References
- Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med. 1996;335:257–265.
- Seely EW, Ecker J. Clinical practice. Chronic hypertension in pregnancy. N Engl J Med. 2011;365:439–446.
- Samuel A, Lin C, Parviainen K, et al. Expectant management of preeclampsia superimposed on chronic hypertension. J Matern Fetal Neonatal Med. 2011;24:907–911.
- American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–1131.
- Sansone M, Sarno L, Saccone G, et al. Risk of preeclampsia in human immunodeficiency virus-infected pregnant women. Obstet Gynecol. 2016;127:1027–1032.
- Smith AH, Bates MN. Confidence limit analyses should replace power calculation in the interpretation of epidemiologic studies. Epidemiology. 1992;3:449–452.
- McNamee R. Regression modelling and other methods to control confounding. Occup Environ Med. 2005;62:500–506.
- Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–1457.
- Valent AM, DeFranco EA, Allison A, et al. Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks. Am J Obstet Gynecol. 2015;212:515.e1–518.